Canopy Growth Drops Drake: Is it the Trendy Stock it Once Was?

What should investors make of the recent dissolution of the dissolution of Drake’s partnership with Canopy Growth (TSX:WEED)(NYSE:CGC)?

| More on:

Canopy Growth (TSX:WEED)(NYSE:CGC) has been making headlines of late. This time, the news centres on the company’s relationship with Canadian rapper Drake.

Canopy Growth has announced it’s severing ties with Drake — a move that seems to have taken the market by surprise.

Here’s what investors should make of this deal.

Canopy Growth pulls the plug on Drake’s More Life

In November 2019, Canopy Growth and Drake announced the launch of More Life, a joint venture that would sell recreational pot and accessories in Canada and around the world. According to the agreement, Canopy decided to turn a Scarborough marijuana cultivation facility into a More Life location for a 40% share in the venture’s equity.

Indeed, it was a hot deal at that time. Companies like Canopy Growth were stumbling over themselves to make celebrity deals. Needless to say, this move garnered significant attention among investors and the media.

This March, Canopy terminated the deal it had in place with Drake. As a result, the company removed the minimum royalty obligations of nearly $33.7 million to More Life from its balance sheet. Canopy’s CEO said that the partnership was not progressing as they had initially intended it would.

Indeed, More Life continues to hold an active trademark for various hemp and cannabis products and accessories. However, I don’t think terminating this deal will be a big blow for this pot player.

Canopy’s mixed track record 

Canopy has had a mixed track record when it comes to celebrity deals. Take, for instance, the Leafs By Snoop brand. This collaboration hasn’t really resulted in much. Leafs by Snoop has managed to put only a handful of products in the domestic market. Comedian Seth Rogen’s Houseplant continues to enjoy some success in the infused beverage space. Lifestyle guru Martha Stewart is also closely associated with Canopy.

That’s a lot of celebrity names for one company to deal with. And these celebrity dealings have generated mixed results. Canopy Growth has a range of specialty branded products and cannabis-infused beverages as a result of these deals. And if more marketing becomes allowed in Canada, Canopy Growth’s portfolio of IP and branded partnerships is top notch.

For now, Canopy Growth is performing just fine, with or without these celebrity deals.

Bottom line

There’s no doubt Canopy Growth has gone mainstream. It’s clear the company isn’t in need of flashy branding deals as it once was. Indeed, Canopy’s cost-cutting efforts appear to be in full swing right now, and I wouldn’t be surprised to see other deals fall apart as a result. Canopy has significantly boosted its operational efficiency metrics, and lowered its SG&A by 41% of late, as a result of such moves.

This is broadly bullish for shareholders, and I think the dissolution of this partnership is largely a non-news event. Investors in Canopy Growth need to stay focused on the long term with this stock.

Fool contributor Chris MacDonald has no position in any stocks mentioned in this article.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »